Joel E. Tepper, MD, the Hector MacLean Distinguished Professor of Cancer Research in the Department of Radiation Oncology wasbe one of twenty recipients of the American Society of Clinical Oncology (ASCO) 2011 Statesman Award.
The award, presented at ASCO’s Annual Meeting in early June in Chicago, IL, recognizes the extraordinary dedication of ASCO members for their voluntary efforts that benefit the Society, the specialty of oncology, and the patients served by the profession. Each year the award is given tovolunteers who have given 20 or more cumulative years of service to the Society.
Dr. Tepper shares the award with another outstanding Lineberger Comprehensive Cancer Center member, Richard M. Goldberg, MD, Distinguished Professor and Chief of the UNC Division of Hematology/Oncology, and Physician-in-Chief of the NC Cancer Hospital.
From the School of Medicine's Interdisciplinary Initiatives Program
To automate treatment planning of head and neck cancers.
Pizer is recognized for his contributions to the field of medical image computing.
In recognition of substantial scientific contributions.
A 5-minute video to orient new patients.
Does sugar feed cancer? How about acidic foods? Does soy impact breast cancer? Should I alter my diet?
A team of UNC researchers developed nanoparticle carriers to successfully deliver therapeutic doses of a cancer drug that had previously failed clinical development due to pharmacologic challenges.
Dr. Zagar is our newest radiation oncologist and clinical faculty member, joining the UNC Department of Radiation Oncology in July 2011.
Our Medical Physics Residency Program received an outstanding review from the CAMPEP accreditation site visitors.
Melanie McNeill has been selected to win a 2011 Oncology Service Excellence Award!
She "follows the money" to make sure patients are billed correctly and that our department is kept compliant.
McNeill promoted to Administrative Support Supervisor
In Adaptive Radiation Therapy
Misty Lehman-Davis has become board-certified in Medical Dosimetry. Congratulations, Misty!
For a mouse model of the oncoprotein Mdm2.